Post-COVID microvascular dysfunction in hospitalized [survivors] is associated with [severity] & persistent cognitive complaints, 2025, van der Knaap+

Discussion in 'Long Covid research' started by SNT Gatchaman, Mar 16, 2025.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
    Post-COVID microvascular dysfunction in hospitalized COVID-19 survivors is associated with acute disease severity and persistent cognitive complaints
    Noa van der Knaap; Simona Klinkhammer; Alida A. Postma; Johanna M.A. Visser-Meily; Janneke Horn; Caroline M. van Heugten; Paulien H.M. Voorter; Merel M. van der Thiel; Gerhard S. Drenthen; Walter H. Backes; Frank van Rosmalen; Susanne van Santen; Bas C.T. van Bussel; Iwan C.C. van der Horst; David E.J. Linden; Marcel J.H. Ariës; Jacobus F.A. Jansen

    OBJECTIVE
    Coronavirus disease 2019 (COVID-19) is known to have adverse effects on the brain's vasculature in some patients. After recovery of the infection, vascular abnormalities may persist, but it remains unclear which pathological pathways play a role in post-COVID vascular and cognitive dysfunction and may contribute to post-COVID cognitive complaints.

    METHODS
    In this observational cohort study, 108 previously hospitalized COVID-19 survivors (general ward: n = 53; intensive care unit (ICU): n = 55) were compared. Cerebral microvascular properties in the cortical gray matter (cGM), normal-appearing white matter (NAWM), and white matter hyperintensities (WMH) were assessed using multi-b-value diffusion MRI around 9 months post-infection and related to acute systemic blood markers and post-COVID cognitive performance and complaints.

    RESULTS
    A lower microvascular perfusion volume fraction (fmv) and blood flow-related measure (fmv·Dmv) were found in ICU compared to general ward patients in the cGM (p = .032; p = .021), NAWM (p = .008; p = .006), and WMH (p = .014; p = .035). No associations were found between diffusion/perfusion metrics and cognitive performance, but a lower fmv in the NAWM was found in those with more cognitive complaints (p = .047). In ICU survivors, higher median blood lactate levels during ICU admission were associated with lower fmv (p = .031) and fmv·Dmv (p = .044) in the NAWM.

    INTERPRETATION
    Significantly more widespread post-COVID cerebral microvascular dysfunction was found in COVID-19 ICU compared to general ward survivors. Post-COVID microvascular dysfunction in the NAWM may be due to more severe cerebral tissue hypoxia at time of the infection and is associated with persisting subjective cognitive complaints, even in absence of objective cognitive problems.

    HIGHLIGHTS

    • Multi-b-value diffusion MRI has potential applications in post-COVID assessment.

    • Post-COVID cerebral microvascular dysfunction is more severe in ICU survivors.

    • Post-COVID microvascular dysfunction may be a result of acute tissue hypoxia.

    • Objective cognition is unaffected by post-COVID cerebral microvascular dysfunction.

    • Subjective complaints are related to post-COVID cerebral microvascular dysfunction.


    Link | PDF (Journal of the Neurological Sciences) [Open Access]
     
    Deanne NZ and Hutan like this.
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
    (Presumably related, the lead author's surname is famous in paediatric neurology/neuroradiology, with an eponymous disease.)
     
    Deanne NZ and forestglip like this.
  3. Eleanor

    Eleanor Senior Member (Voting Rights)

    Messages:
    420
    Though they also say:

     
  4. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
    Deanne NZ, EndME, Sean and 3 others like this.
  5. Eleanor

    Eleanor Senior Member (Voting Rights)

    Messages:
    420
    Absolutely - and also that if someone is experiencing a significant loss of cognitive function compared to how they were before getting ill, it's meaningless to tell them that they are 'objectively' unimpaired because their results are now 'average'.
     
    Deanne NZ, Sean, alktipping and 2 others like this.
  6. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    1,689
    Location:
    Norway
    I did a 3 hr neuropsychological assessment less than a year after I got sick. None of the results were below any of the thresholds. I tried to tell him that my head doesn’t work like it used to, but the neuropsych was adamant that I could not have had any loss of cognitive function. It did not surprise me that he later published about psychosomatic explanations for LC brainfog.
     
    Deanne NZ, Sean, alktipping and 3 others like this.
  7. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
    Further evidence to —


    In sum indicating that normal appearing white matter (NAWM) on routine structural imaging —
    • can be demonstrated to be abnormal with advanced MRI diffusion-weighted imaging protocols
    • which is correlated with subjective cognitive dysfunction (even when routine objective evaluation is normal/insensitive)
    I think these white matter microstructural imaging protocols need to move into routine clinical use for targeted assessment (ie indication: brain fog).
     
    Eleanor, Sean and Deanne NZ like this.
  8. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    1,689
    Location:
    Norway
    Would this indicate that the non-imaging tools are not sensitive enough to detect e.g. brainfog unless it’s very, very severe?
     
    SNT Gatchaman, Sean and Deanne NZ like this.

Share This Page